Search results for "Urinary tract"

showing 5 items of 125 documents

Applications of Ureterosigmoidostomy in Bladder Exstrophy

1999

Until 1994, 95 patients with bladder exstrophy and 20 with incontinent epispadias were operated upon at our department. During the last years more and more exstrophycripples were referred to our institution after primary treatment elsewhere. Thus a total of 56 of the 104 patients had a secondary treatment after failure or unsatisfactory treatment. In contrast to many other institutions, our standard procedure was primary ureterosigmoidostomy and, since 1990 it is completely replaced by a modification of it, the sigma rectum pouch (Mainz Pouch II). After failed primary bladder closure and in patients with short or pathological ureters or insufficient anal sphincter function, we prefer an ile…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentUrinary diversionRectummedicine.diseaseSurgeryBladder exstrophyUreterosigmoidostomymedicine.anatomical_structureBladder augmentationmedicinePouchbusinessContinent Urinary DiversionUpper urinary tract
researchProduct

Prevention and treatment of cystitis during menopause: efficacy of a nutraceutical containing D-mannose, inulin, cranberry, bearberry, Olea europaea,…

2020

Aim of the study: To evaluate the efficacy of a nutraceutical compound containing Uticlin® (D-mannose, cranberry, bearberry, Olea europaea), inulin, Orthosiphon and Lactobacillus acidophilus, in preventing recurrent urinary tract infections (UTIs) in menopausal women. Material and methods: This was a prospective cohort study of menopausal women recruited with a history of recurrent UTIs in the previous twelve months and who intended to treat their bladder problem without the use of antibiotics and/or anti-inflammatories. Women were proposed the use of an oral nutraceutical compound. The drug was taken for ten days, every month. Women were assigned to two parallel cohorts: patients using (gr…

medicine.medical_specialtymedicine.drug_classVisual analogue scaleEndocrinology Diabetes and MetabolismUrinary systemCystitiAntibioticsmenopaused-mannoseGastroenterology03 medical and health sciences0302 clinical medicineLactobacillus acidophilusNutraceuticalInternal medicinemedicineutisProspective cohort studycystitisUrinary tract infection030219 obstetrics & reproductive medicineOrthosiphonbiologybusiness.industryRObstetrics and Gynecologybiology.organism_classificationmedicine.diseasenutraceutical.MenopauseMedicineNutraceuticalurinary tract infectionsbusinessMenopausal Review
researchProduct

Treatment strategies and outcome of the exstrophy–epispadias complex in germany: data from the german CURE-Net

2020

Introduction: To evaluate the impact of reconstructive strategies and post-operative management on short- and long-term surgical outcome and complications of classical bladder exstrophy (CBE) patients' comprehensive data of the multicenter German-wide Network for Congenital Uro-Rectal malformations (CURE-Net) were analyzed. Methods: Descriptive analyses were performed between 34 prospectively collected CBE patients born since 2009, median 3 months old [interquartile range (IQR), 2–4 months], and 113 cross-sectional patients, median 12 years old (IQR, 6–21 years). Results: The majority of included individuals were males (67%). Sixty-eight percent of the prospectively observed and 53% of the …

medicine.medical_specialtypost-operative complicationsTherapieerfolgUrinary systemstaged approachRenal functionEpispadias030204 cardiovascular system & hematologyPediatricsBlasenekstrophie03 medical and health sciences0302 clinical medicineInterquartile rangeMedizinische Fakultät030225 pediatricstreatment strategiesmedicineKomplikationddc:610Treatment outcomePostoperative Phaseoutcome assessmentOriginal ResearchUpper urinary tractbusiness.industrylcsh:RJ1-570lcsh:PediatricsBladder exstrophy; Surgerysingle-stage approachmedicine.diseaseSurgeryBladder exstrophyInguinal herniaexstrophy–epispadias complex (EEC)Pediatrics Perinatology and Child HealthTreatment strategyoperative outcomebusinessDDC 610 / Medicine & health
researchProduct

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between…

2014

serenoa repensMaleProstatic HyperplasiaAntioxidantsSettore MED/24 - UrologiaSeleniumDouble-Blind MethodDrug TherapyLower Urinary Tract SymptomsSerenoa80 and overHumansBPH; LUTS; lycopene; phytotherapy; selenium; serenoa repens; tamsulosin; Aged; Aged 80 and over; Antioxidants; Carotenoids; Double-Blind Method; Drug Therapy Combination; Humans; Italy; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quality of Life; Selenium; Serenoa; Sulfonamides; Treatment Outcome; Urodynamics; Urological AgentsAgedSulfonamidesLUTSphytotherapyMiddle AgedlycopeneCarotenoidsBPH LUTS lycopene phytotherapy selenium serenoa repens tamsulosinUrodynamicsTreatment OutcomeItalyBPHtamsulosinCombinationQuality of LifeUrological Agentsserenoa repens; lycopene; selenium; tamsulosin; LUTS; BPH; phytotherapy
researchProduct

Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli

2005

Type 1 fimbriae ofEscherichia colifacilitate attachment to the host mucosa and promote biofilm formation on abiotic surfaces. The transcriptional regulator LrhA, which is known as a repressor of flagellar, motility and chemotaxis genes, regulates biofilm formation and expression of type 1 fimbriae. Whole-genome expression profiling revealed that inactivation oflrhAresults in an increased expression of structural components of type 1 fimbriae.In vitro, LrhA bound to the promoter regions of the twofimrecombinases (FimB and FimE) that catalyse the inversion of thefimApromoter, and to the invertible element itself. TranslationallacZfusions with these genes and quantification offimEtranscript le…

urinary-tractphase variationFimbrialac operonRepressorsuicide vectorBiologyFlagellummedicine.disease_causeMicrobiologyBacterial AdhesionMicrobiologylysr homologMiceglobal regulatorh-nsEscherichia colimedicineAnimalsHumansgenetic-analysisPromoter Regions GeneticEscherichia coliEscherichia coli InfectionsOligonucleotide Array Sequence AnalysisPhase variationRegulation of gene expressionfim switchEscherichia coli ProteinsGene Expression ProfilingBiofilmGene Expression Regulation Bacterialbiochemical phenomena metabolism and nutritionintegration host factorBiofilmsFimbriae BacterialMutationUrinary Tract Infectionsvirulence determinantsTranscription Factors
researchProduct